Search
for
Sort by
Research 61–90 of 1000+
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Current Treatments for Alopecia Areata
- Nilotinib-Induced Keratosis Pilaris
- Janus kinase inhibitors for alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Alopecia areata – Current understanding and management
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- The Role of Janus Kinase Inhibitors in Dermatology
- Janus Kinase inhibitors in dermatology: a review
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Drug Repurposing Patent Applications April–June 2021
- Premature hair graying: a multifaceted phenomenon
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Protein kinase C is a key target for attenuation of Leigh syndrome by rapamycin
- The role of janus kinases in the treatment of autoimmune skin diseases